Breyer Capital

Activity from announced rounds

All recorded activity
Rounds participated in
8
Confirmed lead rounds
0
4 roles undisclosed
New companies
8
First participation on record · 0 follow-on
Funding in participating rounds
$1.1B
8 disclosed · full round size, not this investor’s share

By stage

Series C+3
Seed2
Series B2
Undisclosed1

By primary sector

Biotech4
Defense tech1
Fintech1
Healthtech1
Proptech1

By country

United States7
South Africa1

Rounds

8 in all activity
Warhound

Warhound develops working dogs for military, law-enforcement and emergency-response teams.

$200MSeed
Participant
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant
Network Bio

Builds AI models trained on patient tissue and clinical data for disease diagnostics

$50MStrategic
Role not disclosed
ParcelBio

Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology

$13MSeed
Role not disclosed
OpenEvidence

Provides AI-powered medical search engine for clinicians

$250MSeries D
Role not disclosed
Yoco

Yoco provides card payments, point-of-sale software and business tools for South African merchants.

$83MSeries C
Participant
Homeward

Homeward provides cash offers and bridge financing for homebuyers and sellers.

$136MSeries B
Participant